Literature DB >> 15683616

Costimulation: critical pathways in the immunologic regulation of asthma.

Abdelouahab Bellou1, Patricia W Finn.   

Abstract

T cells play an important role in the pathogenesis of allergy and asthma. T-cell receptor engagement by antigenic peptides presented to major histocompatibility complex (MHC) class II molecules and activation of costimulatory molecules are crucial in the regulation of T-cell immune responses. Costimulatory molecules are responsible for second signals that induce T-cell activation and proliferation. The best characterized costimulatory pathways include CD80/CD86 interacting with CD28, and a number of additional costimulatory molecules have recently been identified, including members of the tumor necrosis family. The positive signals induced by these molecules are counterbalanced by other members of the costimulatory family, including cytotoxic T lymphocyte-associated antigen (CTLA)-4, programmed death (PD)-1, and B and T lymphocyte attenuator (BTLA), which dampen immune responses. In this review, we describe the fundamental properties of costimulatory molecules and address the influence of costimulatory signals on allergic responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683616     DOI: 10.1007/s11882-005-0089-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  61 in total

1.  CTLA-4 regulates induction of anergy in vivo.

Authors:  R J Greenwald; V A Boussiotis; R B Lorsbach; A K Abbas; A H Sharpe
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

2.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

Authors:  A J Coyle; S Lehar; C Lloyd; J Tian; T Delaney; S Manning; T Nguyen; T Burwell; H Schneider; J A Gonzalo; M Gosselin; L R Owen; C E Rudd; J C Gutierrez-Ramos
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  Pro: the increase in asthma can be ascribed to cleanliness.

Authors:  E von Mutius
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

Review 4.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

5.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

6.  Regulation of CTLA-4 expression during T cell activation.

Authors:  D Perkins; Z Wang; C Donovan; H He; D Mark; G Guan; Y Wang; T Walunas; J Bluestone; J Listman; P W Finn
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

7.  Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation.

Authors:  D A Mark; C E Donovan; G T De Sanctis; S J Krinzman; L Kobzik; P S Linsley; M H Sayegh; J Lederer; D L Perkins; P W Finn
Journal:  Int Immunol       Date:  1998-11       Impact factor: 4.823

Review 8.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  A negative regulatory function of B7 revealed in B7-1 transgenic mice.

Authors:  M P Sethna; L van Parijs; A H Sharpe; A K Abbas; G J Freeman
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

10.  B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).

Authors:  D A Mandelbrot; A J McAdam; A H Sharpe
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  3 in total

1.  CD80 and CD86 knockdown in dendritic cells regulates Th1/Th2 cytokine production in asthmatic mice.

Authors:  Jian-Guo Li; Yu-Mo DU; Zhi-Dong Yan; Jia Yan; Yong-Xun Zhuansun; Rui Chen; Wei Zhang; Su-Ling Feng; Pi-Xin Ran
Journal:  Exp Ther Med       Date:  2016-01-13       Impact factor: 2.447

Review 2.  Stratified approaches to the treatment of asthma.

Authors:  Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

Review 3.  First-line treatment of metastatic melanoma: role of nivolumab.

Authors:  Jeremy Force; April Ks Salama
Journal:  Immunotargets Ther       Date:  2017-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.